Immunovant
Joel Denning, CPA, currently serves as the Director of Tax & Technical Accounting at Immunovant, beginning in February 2024, after previously holding the position of Associate Director in the same department. Prior experience includes roles at Revance as Associate Director and Senior Manager of Tax, and at SmileDirectClub as Tax Manager. Joel Denning has also contributed expertise at PwC as a Senior Associate and at EY, where positions included Senior Tax Accountant, Tax Staff Accountant, and Tax Intern. Earlier in Joel Denning's career, service in the United States Marine Corps as a KC-130J Loadmaster involved conducting flight duties and training junior Marines. Achievements in education include earning a Bachelor of Science in Accounting from Pepperdine University between 2012 and 2016, following earlier education at Royal High School from 2003 to 2007.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.